Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
Frankfurt - Delayed Quote EUR

Newron Pharmaceuticals S.p.A. (NP5.F)

Compare
5.91
-0.41
(-6.49%)
As of 11:20:38 AM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
9,057
9,057
6,094
5,762
5,258
Cost of Revenue
--
--
--
--
295
Gross Profit
--
--
--
--
4,963
Operating Expense
20,686
20,686
19,396
18,119
23,324
Operating Income
-11,629
-11,629
-13,302
-12,357
-18,066
Net Non Operating Interest Income Expense
-4,501
-4,501
-4,291
-2,730
-1,384
Pretax Income
-16,200
-16,200
-17,472
-14,884
-19,618
Tax Provision
24
24
21
17
1,380
Net Income Common Stockholders
-16,224
-16,224
-17,493
-14,901
-20,998
Diluted NI Available to Com Stockholders
-16,224
-16,224
-17,493
-14,901
-20,998
Basic EPS
-0.91
-0.91
-0.98
-0.84
-1.18
Diluted EPS
-0.91
-0.91
-0.98
-0.84
-1.18
Basic Average Shares
17,845
17,845
17,845
17,845
17,845
Diluted Average Shares
17,845
17,845
17,845
17,845
17,845
Total Operating Income as Reported
-11,629
-11,629
-13,302
-12,357
-18,066
Rent Expense Supplemental
98
98
160
115
80
Total Expenses
20,686
20,686
19,396
18,119
23,324
Net Income from Continuing & Discontinued Operation
-16,224
-16,224
-17,493
-14,901
-20,998
Normalized Income
-16,224
-16,224
-17,493
-14,901
-20,998
Interest Income
179
179
56
54
61
Interest Expense
4,168
4,168
3,947
2,918
2,239
Net Interest Income
-4,501
-4,501
-4,291
-2,730
-1,384
EBIT
-12,032
-12,032
-13,525
-11,966
-17,379
EBITDA
-11,831
-11,831
-13,323
-11,757
-17,160
Reconciled Cost of Revenue
--
--
--
--
295
Reconciled Depreciation
201
201
202
209
219
Net Income from Continuing Operation Net Minority Interest
-16,224
-16,224
-17,493
-14,901
-20,998
Normalized EBITDA
-11,831
-11,831
-13,323
-11,757
-17,160
Tax Rate for Calcs
0
0
0
0
0
12/31/2020 - 12/14/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

5KW.F SkinBioTherapeutics plc
0.2620
0.00%
 
2HA.MU Spero Therapeutics Inc
0.5190
-9.74%
 
2GH.BE Merus NV
33.40
-4.57%
 
HQ1.MU Oruka Therapeutics Inc. R
7.30
-11.52%
 
5MC.MU Leap Therapeutics Inc
0.2380
-16.78%
 
5MC.F Leap Therapeutics, Inc.
0.1330
-31.44%
 
HPHA.F Heidelberg Pharma AG
2.8200
+6.42%
 
22Z.SG Zealand Pharma A/S
52.42
-10.09%
 
05Y.F Vivoryon Therapeutics N.V.
1.5980
-8.48%
 
600161.SS TIANTAN BIO
22.02
+6.43%